| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mast Cells | 41 | 2022 | 113 | 7.530 |
Why?
|
| Lysophospholipids | 11 | 2018 | 209 | 2.980 |
Why?
|
| Sphingosine | 12 | 2018 | 315 | 2.910 |
Why?
|
| Receptors, Lysosphingolipid | 5 | 2016 | 63 | 1.480 |
Why?
|
| Eczema | 2 | 2021 | 10 | 1.380 |
Why?
|
| Skin | 10 | 2021 | 451 | 1.330 |
Why?
|
| Hypersensitivity | 5 | 2021 | 52 | 1.110 |
Why?
|
| Immunoglobulin E | 13 | 2022 | 91 | 0.940 |
Why?
|
| Apoptosis | 7 | 2021 | 1641 | 0.820 |
Why?
|
| Ovalbumin | 3 | 2021 | 33 | 0.820 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 17 | 0.770 |
Why?
|
| Mice, Inbred C57BL | 19 | 2021 | 2791 | 0.740 |
Why?
|
| Anaphylaxis | 5 | 2021 | 43 | 0.730 |
Why?
|
| Mice | 29 | 2022 | 8474 | 0.720 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2022 | 167 | 0.720 |
Why?
|
| Interleukin-4 | 8 | 2010 | 69 | 0.720 |
Why?
|
| Inflammation | 5 | 2021 | 1030 | 0.680 |
Why?
|
| Cell Degranulation | 11 | 2022 | 24 | 0.630 |
Why?
|
| Receptors, Neuropeptide | 4 | 2022 | 22 | 0.610 |
Why?
|
| Ceramides | 1 | 2021 | 578 | 0.590 |
Why?
|
| Cells, Cultured | 20 | 2022 | 2673 | 0.570 |
Why?
|
| Animals | 35 | 2022 | 20881 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 4 | 2022 | 290 | 0.530 |
Why?
|
| Signal Transduction | 8 | 2019 | 2689 | 0.480 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 219 | 0.480 |
Why?
|
| Lactic Acid | 3 | 2021 | 86 | 0.480 |
Why?
|
| Lung | 5 | 2014 | 849 | 0.480 |
Why?
|
| Interleukin-6 | 6 | 2017 | 330 | 0.470 |
Why?
|
| Recombinant Proteins | 6 | 2016 | 742 | 0.440 |
Why?
|
| Interleukin-33 | 3 | 2017 | 8 | 0.430 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 2012 | 201 | 0.420 |
Why?
|
| Cytokines | 9 | 2022 | 866 | 0.410 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 597 | 0.400 |
Why?
|
| Receptors, IgE | 7 | 2022 | 22 | 0.360 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 37 | 0.350 |
Why?
|
| Chemokines | 3 | 2018 | 119 | 0.350 |
Why?
|
| Transforming Growth Factor beta1 | 4 | 2017 | 126 | 0.340 |
Why?
|
| Antigens | 5 | 2014 | 90 | 0.340 |
Why?
|
| Fetal Blood | 4 | 2009 | 131 | 0.300 |
Why?
|
| Asthma | 2 | 2012 | 345 | 0.300 |
Why?
|
| Basophils | 2 | 2018 | 57 | 0.280 |
Why?
|
| MicroRNAs | 3 | 2016 | 447 | 0.270 |
Why?
|
| Interleukin-10 | 4 | 2016 | 144 | 0.270 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2005 | 20 | 0.260 |
Why?
|
| Humans | 33 | 2022 | 68618 | 0.250 |
Why?
|
| Stem Cell Factor | 3 | 2003 | 39 | 0.240 |
Why?
|
| Antibodies, Monoclonal | 5 | 2010 | 511 | 0.230 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2009 | 268 | 0.220 |
Why?
|
| Transcription Factors | 2 | 2018 | 753 | 0.210 |
Why?
|
| Neoplasms | 1 | 2014 | 1667 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 2550 | 0.210 |
Why?
|
| Drug Hypersensitivity | 1 | 2022 | 35 | 0.210 |
Why?
|
| Calcium Release Activated Calcium Channels | 1 | 2022 | 1 | 0.200 |
Why?
|
| Neuropeptides | 1 | 2022 | 106 | 0.200 |
Why?
|
| Rosacea | 1 | 2021 | 5 | 0.200 |
Why?
|
| Histamine Release | 2 | 2011 | 47 | 0.200 |
Why?
|
| Macrophages | 3 | 2014 | 647 | 0.190 |
Why?
|
| Female | 11 | 2021 | 38074 | 0.190 |
Why?
|
| Antibodies | 2 | 2019 | 241 | 0.180 |
Why?
|
| Coumarins | 1 | 2020 | 7 | 0.180 |
Why?
|
| Chymases | 4 | 2009 | 5 | 0.180 |
Why?
|
| Phytotherapy | 1 | 2020 | 53 | 0.180 |
Why?
|
| Edema | 1 | 2020 | 66 | 0.170 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2019 | 7 | 0.170 |
Why?
|
| Celiac Disease | 1 | 2019 | 17 | 0.170 |
Why?
|
| Immunosuppressive Agents | 2 | 2017 | 514 | 0.170 |
Why?
|
| Feedback, Physiological | 1 | 2019 | 38 | 0.170 |
Why?
|
| Intestines | 1 | 2019 | 114 | 0.160 |
Why?
|
| Plant Extracts | 1 | 2020 | 122 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 124 | 0.160 |
Why?
|
| Mice, Knockout | 5 | 2022 | 1692 | 0.160 |
Why?
|
| Homeostasis | 3 | 2010 | 291 | 0.160 |
Why?
|
| Cell Line | 5 | 2022 | 1752 | 0.160 |
Why?
|
| Stem Cells | 2 | 2014 | 248 | 0.150 |
Why?
|
| Administration, Topical | 1 | 2017 | 111 | 0.150 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1034 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 240 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 2 | 2014 | 86 | 0.140 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2016 | 4 | 0.140 |
Why?
|
| Calcium Signaling | 3 | 2022 | 97 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 71 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2016 | 29 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2013 | 13 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2016 | 150 | 0.130 |
Why?
|
| Pertussis Toxin | 2 | 2022 | 72 | 0.130 |
Why?
|
| Serine Endopeptidases | 3 | 2005 | 50 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 562 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 145 | 0.130 |
Why?
|
| Receptors, Interleukin-4 | 3 | 2010 | 9 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 532 | 0.120 |
Why?
|
| Indoles | 1 | 2016 | 146 | 0.120 |
Why?
|
| Macrophage Activation | 1 | 2014 | 75 | 0.120 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 100 | 0.120 |
Why?
|
| Substance P | 2 | 2022 | 39 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 18 | 0.110 |
Why?
|
| Cell Separation | 3 | 2018 | 132 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2014 | 190 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 120 | 0.110 |
Why?
|
| Polydioxanone | 1 | 2013 | 2 | 0.110 |
Why?
|
| Bone Marrow Cells | 5 | 2018 | 217 | 0.110 |
Why?
|
| Fetus | 3 | 2004 | 157 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2014 | 220 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2013 | 49 | 0.110 |
Why?
|
| Amino Alcohols | 1 | 2012 | 3 | 0.110 |
Why?
|
| Pyridines | 1 | 2014 | 261 | 0.110 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2012 | 10 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2012 | 626 | 0.100 |
Why?
|
| Leucine | 1 | 1992 | 41 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1992 | 66 | 0.100 |
Why?
|
| Liver | 3 | 2004 | 1118 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 1033 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 111 | 0.100 |
Why?
|
| Chemokine CCL2 | 2 | 2012 | 101 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2012 | 91 | 0.100 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2011 | 1 | 0.100 |
Why?
|
| Tissue Engineering | 1 | 2013 | 212 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2022 | 326 | 0.090 |
Why?
|
| Skin Physiological Phenomena | 1 | 2010 | 13 | 0.090 |
Why?
|
| Rodentia | 1 | 2010 | 27 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 481 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2019 | 1200 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2008 | 447 | 0.080 |
Why?
|
| Calcium | 2 | 2022 | 929 | 0.080 |
Why?
|
| Tryptases | 2 | 2005 | 3 | 0.080 |
Why?
|
| Chemotaxis | 1 | 2008 | 38 | 0.080 |
Why?
|
| Receptors, IgG | 2 | 2012 | 94 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2005 | 1664 | 0.080 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2006 | 24 | 0.070 |
Why?
|
| Propylene Glycols | 1 | 2006 | 16 | 0.070 |
Why?
|
| Phospholipases A | 1 | 2006 | 41 | 0.070 |
Why?
|
| Disease | 1 | 2006 | 41 | 0.070 |
Why?
|
| Immunophenotyping | 2 | 2004 | 110 | 0.070 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 2022 | 10 | 0.070 |
Why?
|
| Male | 5 | 2021 | 37321 | 0.070 |
Why?
|
| Cell Movement | 3 | 2016 | 630 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 247 | 0.060 |
Why?
|
| Leukotriene C4 | 1 | 2005 | 7 | 0.060 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 2005 | 4 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2005 | 52 | 0.060 |
Why?
|
| Complement C5a | 1 | 2005 | 15 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 236 | 0.060 |
Why?
|
| Cell Survival | 2 | 2009 | 901 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2003 | 35 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2004 | 156 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2017 | 432 | 0.050 |
Why?
|
| Anaphylatoxins | 1 | 2022 | 3 | 0.050 |
Why?
|
| Adrenomedullin | 1 | 2022 | 27 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2017 | 331 | 0.050 |
Why?
|
| beta-Arrestins | 1 | 2022 | 80 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2022 | 69 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2003 | 205 | 0.050 |
Why?
|
| Multigene Family | 1 | 2022 | 93 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2022 | 138 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 196 | 0.050 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2021 | 11 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 74 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 1745 | 0.050 |
Why?
|
| Rats | 3 | 2020 | 5300 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2021 | 112 | 0.040 |
Why?
|
| Glutens | 1 | 2019 | 10 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2019 | 17 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2020 | 78 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2019 | 41 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 53 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2013 | 18 | 0.040 |
Why?
|
| Metronidazole | 1 | 2019 | 28 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 1999 | 86 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 307 | 0.040 |
Why?
|
| Ketoprofen | 1 | 2019 | 1 | 0.040 |
Why?
|
| Dinitrophenols | 1 | 2019 | 4 | 0.040 |
Why?
|
| Syk Kinase | 1 | 2019 | 10 | 0.040 |
Why?
|
| Peritoneal Cavity | 1 | 2019 | 25 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1999 | 200 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2019 | 15 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 79 | 0.040 |
Why?
|
| Symporters | 1 | 2019 | 27 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 90 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 56 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2019 | 104 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 434 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2017 | 397 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2019 | 147 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2020 | 195 | 0.040 |
Why?
|
| Peritoneal Lavage | 1 | 2018 | 5 | 0.040 |
Why?
|
| Interleukin-3 | 1 | 2018 | 63 | 0.040 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 122 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 329 | 0.040 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2017 | 61 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 498 | 0.040 |
Why?
|
| B7-1 Antigen | 1 | 1996 | 20 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 2 | 2009 | 11 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mifepristone | 1 | 2016 | 7 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 12 | 0.030 |
Why?
|
| Antigen-Presenting Cells | 1 | 1996 | 50 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 44 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 48 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 2016 | 5 | 0.030 |
Why?
|
| Acyl Coenzyme A | 1 | 2016 | 6 | 0.030 |
Why?
|
| Mevalonic Acid | 1 | 2016 | 27 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2016 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 1996 | 230 | 0.030 |
Why?
|
| Interferon-gamma | 2 | 2012 | 241 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 420 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 204 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 1851 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1996 | 226 | 0.030 |
Why?
|
| Mitochondria | 1 | 1999 | 643 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1996 | 370 | 0.030 |
Why?
|
| Tumor Necrosis Factors | 1 | 2013 | 4 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 212 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 786 | 0.030 |
Why?
|
| Arginase | 1 | 2013 | 15 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1293 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 78 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 63 | 0.030 |
Why?
|
| Endotoxins | 1 | 2013 | 76 | 0.030 |
Why?
|
| Goblet Cells | 1 | 2012 | 9 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 236 | 0.030 |
Why?
|
| Methacholine Chloride | 1 | 2012 | 20 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 1026 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 266 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2012 | 89 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 201 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 117 | 0.030 |
Why?
|
| Interleukins | 1 | 2012 | 79 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 33 | 0.030 |
Why?
|
| Peritoneum | 1 | 1992 | 27 | 0.030 |
Why?
|
| Allergens | 1 | 2012 | 54 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2013 | 164 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 1992 | 107 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Time Factors | 1 | 1999 | 4655 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 175 | 0.020 |
Why?
|
| Temperature | 1 | 1992 | 341 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 62 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 56 | 0.020 |
Why?
|
| Phenotype | 1 | 2013 | 947 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2013 | 384 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2011 | 176 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 248 | 0.020 |
Why?
|
| Monocytes | 1 | 2009 | 210 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 7029 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2009 | 183 | 0.020 |
Why?
|
| G1 Phase | 1 | 2007 | 42 | 0.020 |
Why?
|
| Leukotrienes | 1 | 2006 | 13 | 0.020 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 32 | 0.020 |
Why?
|
| Prostaglandin D2 | 1 | 2006 | 21 | 0.020 |
Why?
|
| Eicosanoids | 1 | 2006 | 16 | 0.020 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2006 | 24 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 123 | 0.020 |
Why?
|
| Cysteine | 1 | 2006 | 112 | 0.020 |
Why?
|
| Biological Transport | 1 | 2006 | 210 | 0.020 |
Why?
|
| Cathepsin G | 1 | 2005 | 3 | 0.020 |
Why?
|
| Cathepsins | 1 | 2005 | 37 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2005 | 76 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 791 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2003 | 147 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2005 | 682 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 541 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 489 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2003 | 237 | 0.010 |
Why?
|
| Cell Count | 1 | 2001 | 248 | 0.010 |
Why?
|
| Minor Lymphocyte Stimulatory Antigens | 1 | 1996 | 1 | 0.010 |
Why?
|
| Superantigens | 1 | 1996 | 7 | 0.010 |
Why?
|
| B7-2 Antigen | 1 | 1996 | 23 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 181 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 101 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1996 | 77 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1996 | 133 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 770 | 0.010 |
Why?
|